Thomas Forbes
Impact in
- Developmental Neuroscience top 10%
-
- Renal cell carcinoma treatment
Papers in
-
- Renal cell carcinoma treatment 2
-
- Congenital Heart Disease Studies 6
- Co-authors
- Vittorio Gallo (3 shared papers)Melissa H. Little (7 shared papers)Sara E. Howden (4 shared papers)Kynan T. Lawlor (3 shared papers)Belinda Phipson (2 shared papers)Lorna J. Hale (2 shared papers)Alicia Oshlack (2 shared papers)Sean B. Wilson (2 shared papers)
- Journals
- Pediatric Nephrology (3 papers)Cancer Research (2 papers)Frontiers in Cell and Developmental Biology (1 paper)Pediatric Transplantation (1 paper)BMC Nephrology (1 paper)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Thomas Forbes
37 papers receiving 989 citations
Peers
Comparison fields: 5 of 103
- Developmental Neuroscience 57
- Pulmonary and Respiratory Medicine 282
- Molecular Biology 471
- Nephrology 34
- Radiology, Nuclear Medicine and Imaging 101
Countries citing papers authored by Thomas Forbes
This map shows the geographic impact of Thomas Forbes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Forbes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Forbes more than expected).
Fields of papers citing papers by Thomas Forbes
This network shows the impact of papers produced by Thomas Forbes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Forbes. The network helps show where Thomas Forbes may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Forbes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 189 | |
| 2 | 2018 | 156 | |
| 3 | 2020 | 83 | |
| 4 | 2020 | 80 | |
| 5 | 2017 | 76 | |
| 6 | 2010 | 46 | |
| 7 | 2003 | 43 | |
| 8 | 2021 | 40 | |
| 9 | 2021 | 26 | |
| 10 | 2018 | 26 | |
| 11 | 2014 | 22 | |
| 12 | 2020 | 21 | |
| 13 | 2015 | 21 | |
| 14 | 2021 | 19 | |
| 15 | 2007 | 19 | |
| 16 | 2001 | 18 | |
| 17 | 2023 | 17 | |
| 18 | 2022 | 14 | |
| 19 | 2022 | 13 | |
| 20 | 2013 | 10 |
About Thomas Forbes
Thomas Forbes is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology, Molecular Biology, Nephrology and Pediatrics, Perinatology and Child Health, having authored 41 papers that have together received 1.0k indexed citations. Recurring topics across this work include Congenital Heart Disease Studies (6 papers), Renal and related cancers (5 papers), Pluripotent Stem Cells Research (3 papers), Renal Diseases and Glomerulopathies (3 papers), Neurogenesis and neuroplasticity mechanisms (2 papers), Renal cell carcinoma treatment (2 papers), Genetic and Kidney Cyst Diseases (2 papers) and Complement system in diseases (2 papers). The work is most often cited by research in Developmental Neuroscience (57 citations), Pulmonary and Respiratory Medicine (282 citations), Molecular Biology (471 citations), Nephrology (34 citations) and Radiology, Nuclear Medicine and Imaging (101 citations). Thomas Forbes has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Vittorio Gallo, Melissa H. Little, Sara E. Howden, Kynan T. Lawlor, Belinda Phipson, Lorna J. Hale, Alicia Oshlack, Sean B. Wilson, Jane Sun and Ernst J. Wolvetang. Their work appears in journals such as Pediatric Nephrology, Cancer Research, Frontiers in Cell and Developmental Biology, Pediatric Transplantation and BMC Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.